Q2 2026 sales rose 9% year-over-year to $9.29 billion, with net income up 9% and diluted EPS up 11%. Adjusted operating profit and EBITDA margins remained strong, supported by higher pricing, volume growth, and productivity gains, despite cost inflation and ongoing legal risks.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.